Literature DB >> 20827767

Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.

Nicolas Lévêque1, Hedia Brixi-Benmansour, Thierry Reig, Fanny Renois, Déborah Talmud, Véronique Brodard, Jean-François Coste, Christophe De Champs, Laurent Andréoletti, Marie-Danièle Diebold.   

Abstract

Although numerous reports have described inflammatory bowel diseases (IBDs) complicated with cytomegalovirus (CMV) infection, the virus participation as an exacerbating factor remains unclear. The aim of this study was thus to clarify the clinical significance of CMV infection complicating exacerbation and to correlate CMV detection with various characteristics in IBD patients. Sixty-seven colonic biopsies obtained from 53 patients admitted for IBD exacerbation were retrospectively analyzed by real-time PCR assay. The CMV genome was detected in seven (10.4%) colonic biopsies related to seven patients (three ulcerative colitis and four Crohn's diseases). Among the patients with IBD studied, patients with evidence of CMV infection were older (P = 0.047), were more likely male gender (relative risk [RR] 4.48; 95% confidence interval [CI] 0.94-21.36), received corticosteroids (RR 3.2; CI 0.79-13.02) or azathioprine (RR 3.17; CI 0.80-12.57) treatments, presented more extended lesions (RR for rectum-sigmoid-left colon 3.75 (0.0-69.37) and for pancolitis 2.45 (0.36-16.23)), and had a more severe disease (RR 3.3; CI 0.87-12.48) than those without CMV infection. Viral loads measured in the colonic mucosa of infected patient ranged from 5 to 236961 genome copies by microgram of total extracted DNA. No relationship was observed between the severity of the disease and the viral load level. Furthermore, CMV disappeared in five infected IBD patients in remission without antiviral agents. In conclusion, these results showed infrequent CMV detection in colonic biopsies of IBD patients during exacerbation leaving open the question of the relationship between CMV reactivation and the onset or the severity of IBD exacerbation. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827767     DOI: 10.1002/jmv.21877

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  When is an Assay of Cytomegalovirus Antigenemia Useful in Detecting Cytomegalovirus Colitis?

Authors:  Kyeong Ok Kim
Journal:  Intest Res       Date:  2015-04-27

3.  Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.

Authors:  Rachele Ciccocioppo; Francesca Racca; Stefania Paolucci; Giulia Campanini; Lodovica Pozzi; Elena Betti; Roberta Riboni; Alessandro Vanoli; Fausto Baldanti; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 4.  Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.

Authors:  Sylvie Pillet; Bruno Pozzetto; Xavier Roblin
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

5.  Cytomegalovirus positive ulcerative colitis: A single center experience and literature review.

Authors:  Uri Kopylov; Gila Sasson; Bella Geyshis; Michal Tepperberg Oikawa; Iris Barshack; Rami Eliakim; Shomron Ben-Horin
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

Review 6.  Strategies for the care of adults hospitalized for active ulcerative colitis.

Authors:  Suresh Pola; Derek Patel; Sonia Ramamoorthy; Elisabeth McLemore; Marianne Fahmy; Jesus Rivera-Nieves; John T Chang; Elisabeth Evans; Michael Docherty; Mark Talamini; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-24       Impact factor: 11.382

7.  Colitis due to Cytomegalovirus and Herpes Simplex Type 2 as a Complication of a First Presentation of Inflammatory Bowel Disease.

Authors:  Tiago Leal; Bruno Arroja; Dalila Costa; Carla Ferreira; João Bruno Soares; Raquel Gonçalves
Journal:  GE Port J Gastroenterol       Date:  2021-03-23

8.  Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.

Authors:  Kacper A Wojtal; Gerhard Rogler; Michael Scharl; Luc Biedermann; Pascal Frei; Michael Fried; Achim Weber; Jyrki J Eloranta; Gerd A Kullak-Ublick; Stephan R Vavricka
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

9.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

10.  The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.

Authors:  Fengming Yi; Jie Zhao; Rishi Vishal Luckheeram; Yuan Lei; Changgao Wang; Sha Huang; Lu Song; Wei Wang; Bing Xia
Journal:  Virol J       Date:  2013-02-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.